Results 11 to 20 of about 15,444 (261)
Micafungin-Induced Suicidal Erythrocyte Death [PDF]
Cellular Physiology and Biochemistry, 2016 Background/Aims: The antifungal drug Micafungin is used for the treatment of diverse fungal infections including candidiasis and aspergillosis. Side effects of Micafungin treatment include microangiopathic hemolytic anemia and thrombocytopenia with ...
Thomas Peter +4 more
doaj +5 more sources
Micafungin induced apoptosis in Candida parapsilosis independent of its susceptibility to micafungin [PDF]
Microbial Cell, 2015 We hypothesized that the cell wall inhibitor micafungin (MICA) induces apoptosis in both MICA-susceptible (MICA-S) and MICA–non-susceptible (MICA-NS) Candida parapsilosis.
Fazal Shirazi +2 more
doaj +4 more sources
Successful Treatment of Refractory <i>Candida auris</i> Ventriculitis With Intraventricular Liposomal Amphotericin B. [PDF]
Clin Case RepABSTRACT We report on a case of a patient in their early 60's with a history of traumatic brain injury, decompressive cranioplasty, and chronic ventriculoperitoneal (VP) shunt who presented from a nursing home with altered mental status and status epilepticus.
Vu CA, Ladd K, Ayoade FO.
europepmc +2 more sources
Micafungin: a sulfated echinocandin [PDF]
The Journal of Antibiotics, 2009 AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
Seiji Hashimoto
openalex +4 more sources
Treatment of Candiduria with Micafungin: A Case Series [PDF]
Canadian Journal of Infectious Diseases and Medical Microbiology, 2006 There has been a gradual increase in the incidence of non‐Candida albicans‐related nosocomial infections. Candida glabrata urinary tract infections have increased in frequency, and treating these infections can be difficult because the organism may be resistant to fluconazole.
Danny D Lagrotteria +2 more
openalex +6 more sources
Journal of Infection in Developing Countries, 2021 Introduction: An echinocandin, such as micafungin, is recommended as first-line treatment for invasive Candida infections in immunocompromised patients. This multicenter, observational, prospective, non- interventional study evaluated the real-world use
Samo Zver +8 more
doaj +1 more source
Journal of Fungi, 2021 Introduction: Micafungin is a recommended echinocandin antifungal agent for candidemia treatment and prophylaxis. However, overuse of echinocandin antifungals may cause resistance.
Yasutaka Sakamoto +11 more
doaj +1 more source
Postantifungal Effect of Micafungin against the Species Complexes of Candida albicans and Candida parapsilosis. [PDF]
PLoS ONE, 2015 Micafungin is an effective antifungal agent useful for the therapy of invasive candidiasis. Candida albicans is the most common cause of invasive candidiasis; however, infections due to non-C.
Sandra Gil-Alonso +3 more
doaj +1 more source
Pharmaceuticals, 2023 Background: Neonates may require higher doses of micafungin than adults to reach the therapeutic effect for increased plasma clearance. Only poor and inconclusive data are available still now to support this hypothesis, especially with regard to central ...
Domenico Umberto De Rose +9 more
doaj +1 more source
Children, 2022 Background: Invasive fungal diseases (IFDs) increase the mortality rate of patients with neutropenia who receive chemotherapy or have previously undergone hematopoietic stem cell transplantation (HSCT).
Bo-Kyung Kim +5 more
doaj +1 more source